Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Review is major blow for the GMC

Patients who self-manage their anticoagulation treatment ach- ieve a similar level of control as those who are managed by a doctor and suffer fewer adverse events, researchers suggest.

The percentage of patients who achieved target INRs was roughly the same in the two groups of patients, at 59 per cent in those who self-managed and 56 per cent in the controls.

And just 2.2 per cent of self-managing patients had a major complication relating to treatment, compared with 7.3 per cent of the patients who were managed conventionally.

Spanish researchers studied 737 patients divided into two groups ­ self-management using a portable coagulometer and self-adjusting treatment dose, and conventional management at a clinic.

The study, published in the Annals of Internal Medicine (January), also found fewer minor haemorrhages and deaths in the self-managing group. But GPs said robust UK evidence was needed.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say